[Intraabdominal and hepatic infections in pediatric cancer patients].
Common complications involved in treating pediatric patients with cancer are bacterial, viral and fungal infections of the gastrointestinal tract including esophagitis, gastritis, duodenitis, colitis and hepatobiliar infections. In many cases there are multiple factors that predispose these patients to gastrointestinal infections, such as granulocytopenia, T-cell dysfunction, and mucosal damage. In addition, newer therapies have changed the spectrum of infection that is seen in these patients. The profound T-cell suppression associated with therapies such as stem cell transplantation has led to the emergence of previously rare infections including cytomegalovirus and adenovirus. This article provides the recommendations of the Infectious Diseases Working Party of the German Society for Pediatric Infectious Diseases (DGPI) and the German Society for Pediatric Hematology/Oncology (GPOH) for diagnosis, prevention, and management of local as well as invasive infections of the gastrointestinal tract.
Ballauff
A
A
Universitätsklinikum Essen, Kinderklinik, Pädiatrische Gastroenterologie und Hepatologie. antje.ballauff@uni-essen.de
Eggert
A
A
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy / Q000009:adverse effects; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy*; D005759:Gastroenteritis / Q000175:diagnosis / Q000188:drug therapy*; D006506:Hepatitis A / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced* / Q000150:complications; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D033581:Stem Cell Transplantation / Q000009:adverse effects*
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents